Integrated Biopharma INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQX
Integrated BioPharma, Inc. announces its 2025 Annual Meeting to address director election, executive compensation, and auditor ratification.
OQX
Integrated BioPharma, Inc. will hold its 2024 Annual Meeting of Stockholders on December 2, 2024, to elect directors and ratify the appointment of its independent auditor.